Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study

被引：0
|
作者：
Zirwas, Matthew [1 ,2 ]
Draelos, Zoe D. [3 ]
DuBois, Janet [4 ]
Kircik, Leon [5 ]
Moore, Angela [6 ]
Gold, Linda Stein [7 ]
Higham, Robert C. [8 ]
Navale, Lynn [8 ]
Burnett, Patrick [8 ]
Berk, David R. [8 ]
机构：
[1] Prob Med Res, Dermatologists Cent States, Waterloo, ON, Canada
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Dermatol Consulting Serv, High Point, NC USA
[4] DermResearch Inc, High Point, NC USA
[5] Icahn Sch Med Mt Sinai, Indiana Med Ctr, Phys Skin Care PLLC & Skin Sci PLLC, New York, NY 10029 USA
[6] Arlington Ctr Dermatol, Arlington, TX USA
[7] Henry Ford Med Ctr, Detroit, MI USA
[8] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
28588
引用
收藏
页码：AB47 / AB47
页数：1
相关论文
共 50 条
  • [41] Pimecrolimus cream 1% for the treatment of facial atopic dermatitis: Exploratory analysis of a double-blind, randomized, vehicle-controlled study in pediatric patients
    Korman, Neil
    Kianifard, Farid
    Parneix-Spike, Anne
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB107 - AB107
  • [42] A Prospective, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy, Safety, and Patient Satisfaction of Tretinoin 0.05% Lotion for Chest Rejuvenation
    Wood, Emily
    Almukhtar, Rawaa
    Gonzalez, Alexes
    Angra, Kunal
    Lipp, Michael
    Fabi, Sabrina
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (06) : 643 - 650
  • [43] Prevention of atopic dermatitis flares by emollients: A double-blind, randomized, vehicle-controlled left-right comparison study
    Angelova-Fischer, I
    Hartmann, K.
    Rippke, F.
    Richter, D.
    Filbry, A.
    Arrowitz, C.
    Weber, T.
    Fischer, T. W.
    Zillikens, D.
    [J]. ALLERGY, 2018, 73 : 295 - 295
  • [44] A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis
    Saraswat, Abir
    Agarwal, Ravindra
    Katare, Om P.
    Kaur, Inderjeet
    Kumar, Bhushan
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (01) : 40 - 45
  • [45] Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: Results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials
    Feldman S.R.
    Matheson R.
    Bruce S.
    Grande K.
    Markowitz O.
    Kempers S.
    Brundage T.
    Wyres M.
    [J]. American Journal of Clinical Dermatology, 2012, 13 (4) : 261 - 271
  • [46] A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis
    Saraswat, A
    Agarwal, R
    Kaur, I
    Katare, OP
    Kumar, B
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 20 - 21
  • [47] Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis Results of Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase III Clinical Trials
    Feldman, Steven R.
    Matheson, Robert
    Bruce, Suzanne
    Grande, Kimberly
    Markowitz, Orit
    Kempers, Steven
    Brundage, Thomas
    Wyres, Melody
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (04) : 261 - 271
  • [48] Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study
    Liu, Lunfei
    Lou, Honggang
    Zhou, Jiong
    Shen, Ying
    Zheng, Min
    Ruan, Zourong
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [49] Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase III, randomized, double-blind, vehicle-controlled study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kaino, Hironobu
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB199 - AB199
  • [50] Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
    Saeki, H.
    Kabashima, K.
    Tokura, Y.
    Murata, Y.
    Shiraishi, A.
    Tamamura, R.
    Randazzo, B.
    Imanaka, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 419 - 427
12345